Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)

Beijing Scitop Bio-tech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	351.04	302.37	298.87	368.24	364.09	339.16
Other Revenue	0.43	0.43	0.37	0.93	0.52	-
Revenue	351.47	302.79	299.24	369.17	364.62	339.16
Revenue Growth (YoY)	16.76%	1.19%	-18.94%	1.25%	7.51%	10.08%
Cost of Revenue	154.36	126.41	135.91	177.29	181.17	175.27
Gross Profit	197.11	176.38	163.33	191.88	183.45	163.88
Selling, General & Admin	69.01	67.9	58.03	56.86	63.26	40.5
Research & Development	36.83	36.33	34.19	22.09	27.15	17.57
Other Operating Expenses	13.22	5.27	4.92	3.76	3.06	2.88
Operating Expenses	119.41	106.35	98.94	83.43	93.81	60.5
Operating Income	77.69	70.03	64.39	108.45	89.64	103.38
Interest Expense	-0.16	-0.25	-0.5	-0.41	-0.44	-
Interest & Investment Income	22.36	28.34	30.13	12.82	18.35	6.87
Other Non Operating Income (Expenses)	0.59	-0.03	-0.05	-0.05	-0.04	-0.04
EBT Excluding Unusual Items	100.49	98.08	93.97	120.81	107.52	110.21
Gain (Loss) on Sale of Investments	1.96	2.01	1.26	0.17	1.55	-
Gain (Loss) on Sale of Assets	0.09	0.65	0.03	-0.01	11.2	0.01
Asset Writedown	-0.31	-0.31	-0	-0	-0.15	-1.03
Other Unusual Items	15.41	8.39	6.78	4.69	4.06	3.98
Pretax Income	117.64	108.83	102.04	125.66	124.17	113.18
Income Tax Expense	18.24	14.47	8.56	15.76	14.63	16.6
Earnings From Continuing Operations	99.4	94.36	93.48	109.89	109.54	96.58
Net Income	99.4	94.36	93.48	109.89	109.54	96.58
Net Income to Common	99.4	94.36	93.48	109.89	109.54	96.58
Net Income Growth	7.27%	0.94%	-14.93%	0.32%	13.42%	3.53%
Shares Outstanding (Basic)	261	262	267	224	222	191
Shares Outstanding (Diluted)	261	262	267	224	222	191
Shares Change (YoY)	-1.26%	-1.87%	19.09%	1.00%	16.50%	14.28%
EPS (Basic)	0.38	0.36	0.35	0.49	0.49	0.51
EPS (Diluted)	0.38	0.36	0.35	0.49	0.49	0.51
EPS Growth	8.63%	2.86%	-28.57%	-0.67%	-2.65%	-9.40%
Free Cash Flow	-200.78	-69.38	-71.21	64.28	42.7	45.39
Free Cash Flow Per Share	-0.77	-0.27	-0.27	0.29	0.19	0.24
Dividend Per Share	0.150	0.150	0.150	0.200	0.333	0.370
Dividend Growth	-	-	-25.00%	-39.99%	-10.02%	-
Gross Margin	56.08%	58.25%	54.58%	51.98%	50.31%	48.32%
Operating Margin	22.11%	23.13%	21.52%	29.38%	24.59%	30.48%
Profit Margin	28.28%	31.16%	31.24%	29.77%	30.04%	28.48%
Free Cash Flow Margin	-57.13%	-22.91%	-23.80%	17.41%	11.71%	13.38%
EBITDA	106.79	94.58	82.87	125.09	104.55	113.23
EBITDA Margin	30.38%	31.23%	27.69%	33.88%	28.68%	33.38%
D&A For EBITDA	29.1	24.55	18.48	16.64	14.91	9.84
EBIT	77.69	70.03	64.39	108.45	89.64	103.38
EBIT Margin	22.11%	23.13%	21.52%	29.38%	24.59%	30.48%
Effective Tax Rate	15.51%	13.30%	8.39%	12.55%	11.79%	14.67%
Revenue as Reported	351.47	302.79	299.24	369.17	364.62	339.16
Advertising Expenses	-	23.49	19.22	7.92	9.94	10.42

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.